How brain signals affect connections and behavior in Alzheimer's disease

Neuromodulatory regulation of cortical functional connectivity

NIH-funded research Yale University · NIH-11074145

This study is looking at how certain brain signals affect thinking and behavior in people with Alzheimer's disease, hoping to learn more about how these changes can help us understand the condition better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionYale University NIH-funded
Lab location1 site (New Haven, United States)
Project IDNIH-11074145 on NIH RePORTER

What this research studies

This research investigates how neuromodulatory signals, particularly acetylcholine and norepinephrine, influence brain connectivity and behavior in individuals with Alzheimer's disease. By using advanced imaging techniques and electrophysiology, the study aims to observe how these signals change during different behavioral states. The goal is to understand the coordination between these signals and their impact on cognitive functions, which could lead to new insights into Alzheimer's disease progression.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.

Not a fit: Patients with other forms of dementia not related to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and potential new treatments for cognitive decline in Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in understanding neuromodulatory signaling in other contexts, but this specific approach in Alzheimer's disease is relatively novel.

Where this research is happening

New Haven, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.